A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer
Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Koontz, Bridget F. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise - Feng, Jing ELSEVIER, 2018, official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:68 ; year:2015 ; number:4 ; pages:683-691 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.eururo.2014.08.009 |
|---|
| Katalog-ID: |
ELV018506143 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV018506143 | ||
| 003 | DE-627 | ||
| 005 | 20230623143609.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eururo.2014.08.009 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015010000004.pica |
| 035 | |a (DE-627)ELV018506143 | ||
| 035 | |a (ELSEVIER)S0302-2838(14)00751-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 500 |q VZ |
| 084 | |a 33.25 |2 bkl | ||
| 084 | |a 31.00 |2 bkl | ||
| 100 | 1 | |a Koontz, Bridget F. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer |
| 264 | 1 | |c 2015 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. | ||
| 650 | 7 | |a Hypofractionation |2 Elsevier | |
| 650 | 7 | |a Genitourinary toxicity |2 Elsevier | |
| 650 | 7 | |a Gastrointestinal toxicity |2 Elsevier | |
| 650 | 7 | |a Prostate-specific antigen |2 Elsevier | |
| 650 | 7 | |a Randomized trials |2 Elsevier | |
| 650 | 7 | |a Prostate cancer |2 Elsevier | |
| 650 | 7 | |a Stereotactic radiation therapy |2 Elsevier | |
| 700 | 1 | |a Bossi, Alberto |4 oth | |
| 700 | 1 | |a Cozzarini, Cesare |4 oth | |
| 700 | 1 | |a Wiegel, Thomas |4 oth | |
| 700 | 1 | |a D’Amico, Anthony |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Feng, Jing ELSEVIER |t Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |d 2018 |d official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology |g Amsterdam [u.a.] |w (DE-627)ELV000464341 |
| 773 | 1 | 8 | |g volume:68 |g year:2015 |g number:4 |g pages:683-691 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.eururo.2014.08.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-MAT | ||
| 936 | b | k | |a 33.25 |j Thermodynamik |j statistische Physik |q VZ |
| 936 | b | k | |a 31.00 |j Mathematik: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 68 |j 2015 |e 4 |h 683-691 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
b f k bf bfk |
|---|---|
| matchkey_str |
koontzbridgetfbossialbertocozzarinicesar:2015----:sseairveohpfatoainopiayaaee |
| hierarchy_sort_str |
2015 |
| bklnumber |
33.25 31.00 |
| publishDate |
2015 |
| allfields |
10.1016/j.eururo.2014.08.009 doi GBVA2015010000004.pica (DE-627)ELV018506143 (ELSEVIER)S0302-2838(14)00751-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl Koontz, Bridget F. verfasserin aut A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy Elsevier Bossi, Alberto oth Cozzarini, Cesare oth Wiegel, Thomas oth D’Amico, Anthony oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:68 year:2015 number:4 pages:683-691 extent:9 https://doi.org/10.1016/j.eururo.2014.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 68 2015 4 683-691 9 045F 610 |
| spelling |
10.1016/j.eururo.2014.08.009 doi GBVA2015010000004.pica (DE-627)ELV018506143 (ELSEVIER)S0302-2838(14)00751-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl Koontz, Bridget F. verfasserin aut A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy Elsevier Bossi, Alberto oth Cozzarini, Cesare oth Wiegel, Thomas oth D’Amico, Anthony oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:68 year:2015 number:4 pages:683-691 extent:9 https://doi.org/10.1016/j.eururo.2014.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 68 2015 4 683-691 9 045F 610 |
| allfields_unstemmed |
10.1016/j.eururo.2014.08.009 doi GBVA2015010000004.pica (DE-627)ELV018506143 (ELSEVIER)S0302-2838(14)00751-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl Koontz, Bridget F. verfasserin aut A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy Elsevier Bossi, Alberto oth Cozzarini, Cesare oth Wiegel, Thomas oth D’Amico, Anthony oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:68 year:2015 number:4 pages:683-691 extent:9 https://doi.org/10.1016/j.eururo.2014.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 68 2015 4 683-691 9 045F 610 |
| allfieldsGer |
10.1016/j.eururo.2014.08.009 doi GBVA2015010000004.pica (DE-627)ELV018506143 (ELSEVIER)S0302-2838(14)00751-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl Koontz, Bridget F. verfasserin aut A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy Elsevier Bossi, Alberto oth Cozzarini, Cesare oth Wiegel, Thomas oth D’Amico, Anthony oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:68 year:2015 number:4 pages:683-691 extent:9 https://doi.org/10.1016/j.eururo.2014.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 68 2015 4 683-691 9 045F 610 |
| allfieldsSound |
10.1016/j.eururo.2014.08.009 doi GBVA2015010000004.pica (DE-627)ELV018506143 (ELSEVIER)S0302-2838(14)00751-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl Koontz, Bridget F. verfasserin aut A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy Elsevier Bossi, Alberto oth Cozzarini, Cesare oth Wiegel, Thomas oth D’Amico, Anthony oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:68 year:2015 number:4 pages:683-691 extent:9 https://doi.org/10.1016/j.eururo.2014.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 68 2015 4 683-691 9 045F 610 |
| language |
English |
| source |
Enthalten in Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise Amsterdam [u.a.] volume:68 year:2015 number:4 pages:683-691 extent:9 |
| sourceStr |
Enthalten in Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise Amsterdam [u.a.] volume:68 year:2015 number:4 pages:683-691 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Thermodynamik statistische Physik Mathematik: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
Hypofractionation Genitourinary toxicity Gastrointestinal toxicity Prostate-specific antigen Randomized trials Prostate cancer Stereotactic radiation therapy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| authorswithroles_txt_mv |
Koontz, Bridget F. @@aut@@ Bossi, Alberto @@oth@@ Cozzarini, Cesare @@oth@@ Wiegel, Thomas @@oth@@ D’Amico, Anthony @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000464341 |
| dewey-sort |
3610 |
| id |
ELV018506143 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018506143</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623143609.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eururo.2014.08.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015010000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018506143</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0302-2838(14)00751-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.25</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Koontz, Bridget F.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypofractionation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genitourinary toxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gastrointestinal toxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate-specific antigen</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Randomized trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stereotactic radiation therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bossi, Alberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cozzarini, Cesare</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiegel, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D’Amico, Anthony</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Feng, Jing ELSEVIER</subfield><subfield code="t">Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise</subfield><subfield code="d">2018</subfield><subfield code="d">official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000464341</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:68</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:683-691</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.eururo.2014.08.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.25</subfield><subfield code="j">Thermodynamik</subfield><subfield code="j">statistische Physik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.00</subfield><subfield code="j">Mathematik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">68</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">683-691</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Koontz, Bridget F. |
| spellingShingle |
Koontz, Bridget F. ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer |
| authorStr |
Koontz, Bridget F. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000464341 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 500 - Natural sciences & mathematics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy Elsevier |
| topic |
ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy |
| topic_unstemmed |
ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy |
| topic_browse |
ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Hypofractionation Elsevier Genitourinary toxicity Elsevier Gastrointestinal toxicity Elsevier Prostate-specific antigen Elsevier Randomized trials Elsevier Prostate cancer Elsevier Stereotactic radiation therapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a b ab c c cc t w tw a d ad |
| hierarchy_parent_title |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| hierarchy_parent_id |
ELV000464341 |
| dewey-tens |
610 - Medicine & health 500 - Science |
| hierarchy_top_title |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000464341 |
| title |
A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer |
| ctrlnum |
(DE-627)ELV018506143 (ELSEVIER)S0302-2838(14)00751-9 |
| title_full |
A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer |
| author_sort |
Koontz, Bridget F. |
| journal |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| journalStr |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
683 |
| author_browse |
Koontz, Bridget F. |
| container_volume |
68 |
| physical |
9 |
| class |
610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Koontz, Bridget F. |
| doi_str_mv |
10.1016/j.eururo.2014.08.009 |
| dewey-full |
610 500 |
| title_sort |
a systematic review of hypofractionation for primary management of prostate cancer |
| title_auth |
A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer |
| abstract |
Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. |
| abstractGer |
Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. |
| abstract_unstemmed |
Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT |
| container_issue |
4 |
| title_short |
A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer |
| url |
https://doi.org/10.1016/j.eururo.2014.08.009 |
| remote_bool |
true |
| author2 |
Bossi, Alberto Cozzarini, Cesare Wiegel, Thomas D’Amico, Anthony |
| author2Str |
Bossi, Alberto Cozzarini, Cesare Wiegel, Thomas D’Amico, Anthony |
| ppnlink |
ELV000464341 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.eururo.2014.08.009 |
| up_date |
2024-07-06T18:59:51.072Z |
| _version_ |
1803857314261762049 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018506143</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623143609.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eururo.2014.08.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015010000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018506143</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0302-2838(14)00751-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.25</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Koontz, Bridget F.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Technological advances in radiation therapy delivery have permitted the use of high-dose-per-fraction radiation therapy (RT) for early-stage prostate cancer (PCa). Level 1 evidence supporting the safety and efficacy of hypofractionated RT is evolving as this modality becomes more widely utilized and refined.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hypofractionation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genitourinary toxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Gastrointestinal toxicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate-specific antigen</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Randomized trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stereotactic radiation therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bossi, Alberto</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cozzarini, Cesare</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiegel, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">D’Amico, Anthony</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Feng, Jing ELSEVIER</subfield><subfield code="t">Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise</subfield><subfield code="d">2018</subfield><subfield code="d">official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000464341</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:68</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:683-691</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.eururo.2014.08.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.25</subfield><subfield code="j">Thermodynamik</subfield><subfield code="j">statistische Physik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.00</subfield><subfield code="j">Mathematik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">68</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">683-691</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.402237 |